Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
about
Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilizationAMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agentEfficient commitment to functional CD34+ progenitor cells from human bone marrow mesenchymal stem-cell-derived induced pluripotent stem cellsGenome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.Individual patient data meta-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration.Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.Hematopoietic differentiation of embryoid bodies derived from the human embryonic stem cell line SNUhES3 in co-culture with human bone marrow stromal cellsThe costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemiaGranulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.Murine mobilized peripheral blood stem cells have a lower capacity than bone marrow to induce mixed chimerism and tolerance.Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.Successful peripheral blood stem cell mobilization using pegfilgrastim in allogeneic stem cell transplantation.Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].Harvesting, processing and inventory management of peripheral blood stem cellsMobilization of hematopoietic stem cells from the bone marrow niche to the blood compartmentEffects of bone marrow cell transplant on thyroid function in an I131-induced low T4 and elevated TSH rat modelGranulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders.Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.Transplantation of hematopoietic stem cells from the peripheral blood.Haematopoietic stem cell transplantation to treat aplastic anaemia.Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.Dendritic cells in allogeneic hematopoietic stem cell transplantation.Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftmentMucosal graft-vs-host disease.Stem cell-based therapy in gastroenterology and hepatology.Human dendritic cells and transplant outcome.Lineage development of hematopoietic stem and progenitor cells.Quantification of biological variation in blood-based therapy--a summary of a meta-analysis to inform manufacturing in the clinic.Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era: our perspectives.Birth order and transplantation outcome in HLA-identical sibling stem cell transplantation: an analysis on behalf of the Center for International Blood and Marrow TransplantationAdvances in mobilization for the optimization of autologous stem cell transplantation.Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias.Bone marrow stem/progenitor cell mobilization in C57BL/6J and BALB/c mice.Intestinal stem cells and celiac diseaseCombination of intensive chemotherapy and anticancer vaccines in the treatment of human malignancies: the hematological experienceUse of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.
P2860
Q24299060-ABE1A399-E530-47EC-A7B3-561AFCDA6064Q28286940-72B7FE90-DAD9-4F9A-ADA4-F140D6B82FC1Q28482184-B855A4A5-21B5-49DA-9C11-1258E5576DBFQ30252934-E20778DE-952F-4935-8EA5-318B491A9579Q30997153-141543D1-5B05-4C9A-AB5B-69A8F90FE8F2Q31058878-6CE4A52C-FDDB-454E-9E2B-EC8286C572F8Q33364554-8C2FC993-798E-4450-B473-BB9C6A01FC52Q33607130-0D06A0B2-2BA6-46F4-AD9E-933CCF6F3AADQ34057955-B8B9350D-0DFD-430B-ADB2-030A1B971315Q34156527-DF555F5B-44D0-47D5-B151-A3EC42EDAFECQ34356227-5E4B2B0C-6E85-489C-B277-79D76E116C17Q34499853-434CA668-89F4-4B58-AF28-9DE25816DECDQ34659309-582061CE-0629-4495-A168-BB9D37A0B41FQ34707280-93B37E9A-942A-4D42-880A-F3AE961FC2F4Q35183791-4BE44DC2-6F2C-45C7-BAC2-693EEB166030Q35199782-4AE71EF2-790F-4A46-91B4-953AD7415EB4Q35579264-360C6F4A-99E0-42B8-94CF-90272EF025B6Q35614119-B4898D89-BACD-48FA-8860-F3F8674943B6Q35680360-81EA16FA-72FD-4A2E-9003-80D32C864312Q35909475-094CAF8A-1973-4416-862A-0E4135B9BE65Q35925091-AEC949C3-1567-4EA1-B6B5-283ECE20B526Q36014986-BBC707C8-DA38-400A-876F-F59623D3561AQ36077380-8A6718C8-7030-4308-AAF1-6C979BA47843Q36150480-287B80A6-433D-4A2A-9FDC-0E60332B602BQ36262506-B332E2D7-C3C9-4033-B62C-25552EDA01EBQ36272587-03BB0231-97C1-4A5A-9189-4C915CBA2C8EQ36403190-AAF6EE4C-6A54-4237-B3CB-6F0CF3686AAFQ36974835-75F26C7A-05FD-447A-B581-3A7A54E10481Q37157674-35F88371-721E-49D6-AFE1-993003D83958Q37190393-3DFFD54D-34DD-45C9-B4FF-C3F0274C9E19Q37216615-29BA9108-BD60-4033-9375-F77771FE6CF1Q37243360-CDF285A1-1BB3-4F83-A94C-473CB300D5EDQ37362810-440239EA-565C-40E6-867A-1C17941A9A9BQ37396289-7B1C289D-2220-41BF-A3B0-E8F7C1B50046Q37551715-CB8C1182-77F8-41A0-8F1C-108F176A6F61Q37576040-5436379F-6282-4F89-A80D-C27A51149679Q37681191-86F18FC4-DA03-4B3A-AF7D-5046990F714DQ37723494-D9A3C3D3-C945-4476-BEE9-BD8B12E79240Q37772085-15A0BB02-8B37-42F0-9F07-3F1B8AC92E56Q37772229-981A8072-8EE2-4F10-BBDE-06177B634BB4
P2860
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@ast
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@en
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@nl
type
label
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@ast
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@en
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@nl
prefLabel
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@ast
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@en
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@nl
P1433
P1476
Peripheral blood stem cell ver ...... matopoietic stem cells matter?
@en
P2093
Anderlini P
Körbling M
P304
P356
10.1182/BLOOD.V98.10.2900
P407
P577
2001-11-01T00:00:00Z